Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
CDC6 | MCM2 | MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 | 9.88E4 | Evidence | O | ||||
CDC6 | CCNB2 | CCNB2: G2/mitotic-specific cyclin-B2 | 1.59E4 | Evidence | |||||
CDC6 | MCM7 | MCM7, CDC47, MCM2: DNA replication licensing factor MCM7 | 1.59E4 | Evidence | |||||
CDC6 | CCNB1 | Cyclin B1 | 7.89E3 | Evidence | |||||
CDC6 | MCM5 | MCM5, CDC46: DNA replication licensing factor MCM5 | 7.47E3 | Evidence | |||||
CDC6 | ORC2L | ORC2L, ORC2: Origin recognition complex subunit 2 | 4.51E3 | Evidence | O | ||||
CDC6 | CDK2 | CDK2: Cell division protein kinase 2 | 820.0 | Evidence | |||||
CDC6 | ORC4L | ORC4L: Origin recognition complex subunit 4 | 594.0 | Evidence | |||||
CDC6 | ORC5L | ORC5L: Origin recognition complex subunit 5 | 423.0 | Evidence | O | ||||
CDC6 | MCM3 | MCM3: DNA replication licensing factor MCM3 | 372.0 | Evidence | O | ||||
CDC6 | MCM4 | MCM4, CDC21: DNA replication licensing factor MCM4 | 372.0 | Evidence | |||||
CDC6 | PCNA | PCNA: Proliferating cell nuclear antigen | 226.0 | Evidence | O | ||||
CDC6 | CKS1B | CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 | 181.0 | Evidence | |||||
CDC6 | ORC1L | ORC1L, ORC1, PARC1: Origin recognition complex subunit 1 | 174.0 | Evidence | O | ||||
CDC6 | BRCA2 | BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein | 71.40 | Evidence | |||||
CDC6 | MCM6 | MCM6: DNA replication licensing factor MCM6 | 60.20 | Evidence | |||||
CDC6 | PSMC2 | PSMC2, MSS1: 26S protease regulatory subunit 7 | 56.30 | Evidence | |||||
CDC6 | GTF2B | GTF2B, TF2B, TFIIB: Transcription initiation factor IIB | 51.50 | Evidence | |||||
CDC6 | RB1 | RB1: Retinoblastoma-associated protein | 49.60 | Evidence | |||||
CDC6 | BAZ1B | BAZ1B, WBSC10, WBSCR10, WBSCR9, WSTF: Bromodomain adjacent to zinc finger domain | 46.90 | Evidence | |||||
CDC6 | BRCA1 | BRCA1, RNF53: Breast cancer type 1 susceptibility protein | 45.90 | Evidence | |||||
CDC6 | MYBL2 | MYBL2, BMYB: Myb-related protein B | 35.00 | Evidence | |||||
CDC6 | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 29.50 | Evidence | |||||
CDC6 | CDK4 | CDK4: Cell division protein kinase 4 | 29.50 | Evidence | |||||
CDC6 | RFC5 | RFC5: Replication factor C subunit 5 | 28.60 | Evidence | |||||
CDC6 | RFC3 | RFC3: Replication factor C subunit 3 | 28.60 | Evidence | |||||
CDC6 | RFC4 | RFC4: Replication factor C subunit 4 | 28.60 | Evidence | |||||
CDC6 | ORC6L | ORC6L: Origin recognition complex subunit 6 | 28.2 | Evidence | O | ||||
CDC6 | ESPL1 | N/A | 28.00 | Evidence | |||||
CDC6 | AKAP8 | AKAP8, AKAP95: A-kinase anchor protein 8 | 26.00 | Evidence | |||||
CDC6 | VCP | VCP: Transitional endoplasmic reticulum ATPase | 25.10 | Evidence | |||||
CDC6 | CCNA2 | CCNA2, CCN1, CCNA: Cyclin-A2 | 23.90 | Evidence | O | ||||
CDC6 | RPA2 | RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit | 19.70 | Evidence | |||||
CDC6 | CCNF | CCNF: G2/mitotic-specific cyclin-F | 19.00 | Evidence | |||||
CDC6 | CCNH | CCNH: Cyclin-H | 18.90 | Evidence | |||||
CDC6 | MSH6 | MSH6, GTBP: DNA mismatch repair protein MSH6 | 17.90 | Evidence | |||||
CDC6 | LIG1 | LIG1: DNA ligase 1 | 17.90 | Evidence | |||||
CDC6 | PBK | PBK, TOPK: Lymphokine-activated killer T-cell-originated protein kinase | 17.90 | Evidence | |||||
CDC6 | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 17.80 | Evidence | |||||
CDC6 | SFRS1 | SFRS1, ASF, OK/SW-cl.3, SF2, SF2P33: Splicing factor, arginine/serine-rich 1 | 17.80 | Evidence | |||||
CDC6 | RBL1 | RBL1: Retinoblastoma-like protein 1 | 17.60 | Evidence | |||||
CDC6 | PLK1 | PLK1, PLK: Serine/threonine-protein kinase PLK1 | 17.10 | Evidence | |||||
CDC6 | RPA1 | RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit | 17.00 | Evidence | |||||
CDC6 | HMGN2 | HMGN2, HMG17: Non-histone chromosomal protein HMG-17 | 16.10 | Evidence | |||||
CDC6 | CAD | CAD: CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase | 15.10 | Evidence | |||||
CDC6 | CCNE1 | CCNE1, CCNE: G1/S-specific cyclin-E1 | 13.40 | Evidence | |||||
CDC6 | TAL1 | TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 | 12.60 | Evidence |